Related Experiment Video
Updated: Mar 22, 2026

Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
Published on: April 11, 2025
Hyperglycemic Conditions Prime Cells for RIP1-dependent Necroptosis
Timothy J LaRocca1, Sergey A Sosunov2, Nicole L Shakerley1
1From the Department of Basic and Social Sciences, Albany College of Pharmacy and Health Sciences, Albany, New York 12208.
High glucose levels enhance necroptosis, a programmed cell death pathway dependent on RIP1 kinase. This finding suggests hyperglycemia increases susceptibility to cell death and exacerbates injuries like brain hypoxia-ischemia.
Area of Science:
- Cell Biology
- Immunology
- Pathology
Background:
- Necroptosis is a distinct programmed cell death (PCD) pathway regulated by RIP1.
- Glycolysis supports necroptosis effectors like advanced glycation end products (AGEs) and reactive oxygen species (ROS).
Purpose of the Study:
- To investigate the effect of hyperglycemia on necroptosis.
- To determine if high glucose levels alter programmed cell death pathways.
Main Methods:
- Primary red blood cells, Jurkat T cells, and U937 monocytes were exposed to hyperglycemic glucose levels.
- RIP1 inhibition was used to confirm necroptosis dependence.
- Protein levels of RIP1, RIP3, and MLKL were analyzed.
- A mouse model of brain hypoxia-ischemia injury was employed.
Main Results:
- Hyperglycemia significantly enhanced RIP1-dependent necroptosis in tested cell types.
- Increased RIP1, RIP3, and MLKL protein levels were observed in nucleated cells, independent of transcriptional regulation.
- High glucose inhibited extrinsic apoptosis, shifting the PCD balance towards necroptosis.
- Hyperglycemia exacerbated brain hypoxia-ischemia injury in mice, which was mitigated by necroptosis inhibition.
Conclusions:
- Hyperglycemia primes cells for necroptosis, increasing susceptibility to cell death.
- Local glucose concentrations can modulate the balance between different PCD pathways.
- Glucose-mediated effects on PCD have implications for clinical outcomes and disease exacerbation.
More Related Videos
08:55Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
The Extrinsic Apoptotic Pathway
Apoptosis